Dexamethasone for severe COVID-19: how does it work at cellular and molecular levels?
The coronavirus disease 2019 (COVID-19) caused by infection of the severe respiratory
syndrome coronavirus-2 (SARS-CoV-2) significantly impacted human society. Recently, the …
syndrome coronavirus-2 (SARS-CoV-2) significantly impacted human society. Recently, the …
Corticosteroids: A boon or bane for COVID-19 patients?
Several drugs and antibodies have been repurposed to treat COVID-19. Since the outcome
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
Corticosteroids for COVID-19: worth it or not?
Pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induced
COVID-19 implied the presence of excessive proinflammatory cytokines and chemokines in …
COVID-19 implied the presence of excessive proinflammatory cytokines and chemokines in …
Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is characterized by a wide spectrum of symptom …
syndrome coronavirus 2 (SARS-CoV-2), is characterized by a wide spectrum of symptom …
[HTML][HTML] The Role of Glucocorticoids in the Management of COVID-19
VI Alexaki, H Henneicke - Hormone and Metabolic Research, 2021 - thieme-connect.com
Coronavirus disease 2019 (COVID-19), caused by an infection with the novel coronavirus
SARS-CoV-2, has resulted in a global pandemic and poses an emergency to public health …
SARS-CoV-2, has resulted in a global pandemic and poses an emergency to public health …
Corticosteroids in COVID-19: pros and cons
The wide and rapid spread of the COVID-19 pandemic has placed an unanticipated burden
on the global healthcare sector. This necessitated a swift response from the international …
on the global healthcare sector. This necessitated a swift response from the international …
Dexamethasone for the treatment of coronavirus disease (COVID-19): a review
MH Ahmed, A Hassan - SN comprehensive clinical medicine, 2020 - Springer
Abstract The World Health Organization (WHO) declared COVID-19 (novel coronavirus) as a
global pandemic in the middle of March 2020, after the disease spread to more than 150 …
global pandemic in the middle of March 2020, after the disease spread to more than 150 …
Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic
S Noreen, I Maqbool, A Madni - European journal of pharmacology, 2021 - Elsevier
The current outbreak of novel COVID-19 challenges the development of an efficient
treatment plan as soon as possible. Several promising treatment options stand out as …
treatment plan as soon as possible. Several promising treatment options stand out as …
Role of dexamethasone and methylprednisolone corticosteroids in coronavirus disease 2019 hospitalized patients: a review
The WHO announced coronavirus disease 2019 (COVID-19) as a pandemic disease
globally on March 11, 2020, after it emerged in China. The emergence of COVID-19 has …
globally on March 11, 2020, after it emerged in China. The emergence of COVID-19 has …
Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data
A Sharma - Gene, 2021 - Elsevier
Dexamethasone, a synthetic glucocorticoid, has previously shown mortality benefit in severe
coronavirus disease 2019 (COVID-19) in a randomized controlled trial. As the illness is …
coronavirus disease 2019 (COVID-19) in a randomized controlled trial. As the illness is …